Browse > Article
http://dx.doi.org/10.5012/jkcs.2015.59.5.466

Recombinant Human Laforin Expressed in Insect Cells: Expression, Purification, and Biochemical Characterizations  

Choi, Ji-Woong (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center)
Bong, Seoung Min (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center)
Yang, Seung Won (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center)
Jang, Hyonchol (Division of Cancer Biology, Research Institute, National Cancer Center)
Park, SangYoun (School of Systems Biomedical Science, Soongsil University)
Kim, Seung Jun (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology)
Lee, Byung Il (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center)
Publication Information
Journal of the Korean Chemical Society / v.59, no.5, 2015 , pp. 466-470 More about this Journal
Keywords
Laforin; EPM2A; Baculovirus; Insect cells; Phosphatase; Glycogen; Lafora disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Minassian, B. A.; Lee, J. R.; Herbrick, J. A.; Huizenga, J.; Soder, S.; Mungall, A. J.; Dunham, I.; Gardner, R.; Fong, C. Y.; Carpenter, S.; Jardim, L.; Satishchandra, P.; Andermann, E.; Snead, O. C., 3rd; Lopes-Cendes, I.; Tsui, L. C.; DelgadoEscueta, A. V.; Rouleau, G. A.; Scherer, S. W., Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 1998, 20(2), 171.   DOI
2 Brewer, M. K.; Husodo, S.; Dukhande, V. V.; Johnson, M. B.; Gentry, M. S., Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli. BMC biochemistry 2014, 15(1), 8.   DOI
3 Jarvis, D. L., Baculovirus Expression Vectors. In The Baculoviruses; Plenum Press: New York, 1997, Miller, L.K., Ed.; pp 389-431.
4 Roma-Mateo, C.; Solaz-Fuster Mdel, C.; Gimeno-Alcaniz, J. V.; Dukhande, V. V.; Donderis, J.; Worby, C. A.; Marina, A.; Criado, O.; Koller, A.; Rodriguez De Cordoba, S.; Gentry, M. S.; Sanz, P., Biochem. J. 2011, 439(2), 265.   DOI
5 Raththagala, M.; Brewer, M. K.; Parker, M. W.; Sherwood, A. R.; Wong, B. K.; Hsu, S.; Bridges, T. M.; Paasch, B. C.; Hellman, L. M.; Husodo, S.; Meekins, D. A.; Taylor, A. O.; Turner, B. D.; Auger, K. D.; Dukhande, V. V.; Chakravarthy, S.; Sanz, P.; Woods, V. L., Jr.; Li, S.; Vander Kooi, C. W.; Gentry, M. S., Mol. Cell 2015, 57(2), 261.   DOI
6 Wang, J.; Stuckey, J. A.; Wishart, M. J.; Dixon, J. E., A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J. Biol. Chem. 2002, 277(4), 2377.   DOI
7 Cantarel, B. L.; Coutinho, P. M.; Rancurel, C.; Bernard, T.; Lombard, V.; Henrissat, B., The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res. 2009, 37 (Database issue), D233.   DOI
8 Ganesh, S.; Tsurutani, N.; Suzuki, T.; Hoshii, Y.; Ishihara, T.; Delgado-Escueta, A. V.; Yamakawa, K., The carbohydratebinding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem. Biophys. Res. Commun. 2004, 313(4), 1101.   DOI
9 Tonks, N. K., Protein tyrosine phosphatases: from genes, to function, to disease. Nature Reviews. Mol. Cell Biology 2006, 7(11), 833.
10 Alonso, A.; Sasin, J.; Bottini, N.; Friedberg, I.; Friedberg, I.; Osterman, A.; Godzik, A.; Hunter, T.; Dixon, J.; Mustelin, T., Protein tyrosine phosphatases in the human genome. Cell 2004, 117(6), 699.   DOI
11 Tagliabracci, V. S.; Heiss, C.; Karthik, C.; Contreras, C. J.; Glushka, J.; Ishihara, M.; Azadi, P.; Hurley, T. D.; DePaoliRoach, A. A.; Roach, P. J., Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab. 2011, 13(3), 274.   DOI
12 Girard, J. M.; Le, K. H.; Lederer, F., Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease. Biochimie 2006, 88(12), 1961.   DOI
13 Dukhande, V. V.; Rogers, D. M.; Roma-Mateo, C.; Donderis, J.; Marina, A.; Taylor, A. O.; Sanz, P.; Gentry, M. S., Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PloS one 2011, 6(8), e24040.   DOI
14 (a) Gentry, M. S.; Roma-Mateo, C.; Sanz, P., Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. The FEBS Journal 2013, 280(2), 525;   DOI
15 (b) Gentry, M. S.; Dixon, J. E.; Worby, C. A., Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem. Sci. 2009, 34(12), 628.   DOI
16 Ganesh, S.; Puri, R.; Singh, S.; Mittal, S.; Dubey, D., Recent advances in the molecular basis of Lafora’s progressive myoclonus epilepsy. J. Hum. Genet. 2006, 51(1), 1.   DOI
17 Tagliabracci, V. S.; Turnbull, J.; Wang, W.; Girard, J. M.; Zhao, X.; Skurat, A. V.; Delgado-Escueta, A. V.; Minassian, B. A.; Depaoli-Roach, A. A.; Roach, P. J., Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(49), 19262.   DOI